News & Articles

StemFit for mesenchymal stem cells (MSC) is the latest addition to the StemFit family of stem cell media

We speak with Dr. Ed Emmott, founder of The Emmott Lab & COVID-19 Mass Spec Coalition member, about his latest research into the disease

Affimer-based research assay launched alongside performance data published by Bruker

A comprehensive and interactive digital guide, to real-time live-cell imaging and analysis

Sebastian Peck discusses an automated high-content imaging solution designed to deliver more precise results from complex biological assays

Leinco Technologies has launched the COVID-19 ImmunoRank Neutralization ELISA Test Kit

Watch this on-demand webinar to discover the critical factors when choosing an assay for coronavirus testing

Join us on Monday, September 21, to learn about assay development for high-throughput screening

Read this application note to discover how T cell activation assays can help accelerate COVID-19 vaccine development

The real-time PCR workflow has a capacity of up to 6,000 tests per day per system, and demonstrated 100% agreement with authorized nasopharyngeal assays

IgM assay has 95.51% positive predictive value even when disease incidence is only 3%

Leveraging GenMark’s eSensor XT-8 platform hopes to expand COVID-19 diagnostic testing capacity

Watch this on-demand webinar to learn all about the new alternative to live virus neutralization and immunoglobulin detection

Enables labs to quickly ramp up testing capacity and generate results faster

This powerful new solution aims to provide more accurate COVID-19 antibody detection

Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing

Join us on Wednesday, August 26, to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours

Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes

With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response

Dr. Nallasivam Palanisamy, Henry Ford Cancer Institute, discusses his discovery of the first pseudogene-associated recurrent gene fusion in cancer and the potential for this robust biomarker for application beyond prostate cancer

Developed with enhanced technology, this new assay provides high-quality staining with improved turnaround time

New assays for Campylobacter, STEC, Vibrio and Staphylococcus aureus enable more comprehensive pathogen testing for all food manufacturers